journal article·2026-03

Endogenous plasmid engineering of probiotic Escherichia coli Nissle 1917 for the antibiotic-free indigo production

Jia-Qi Xu, Dong Yu, Guoqing Zhou, Fu-Cheng He, Li-Jing Mao, Min Xiong, Longxiang Zhou, Feng-Qing Wang, Liang-Bin Xiong

Dyes and Pigments· Volume 246
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Transgenic Plants and Applications · Microbial Metabolism and Applications · Bioeconomy and Sustainability Development

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Modern industrial and pharmacological applications of indigo dye and its derivatives--a review
2. Early Pre-hispanic use of indigo blue in Peru10.1126/sciadv.1501623 ↗
3. Research progress of food colouring agent
4. Production of indigo by recombinant bacteria10.1186/s40643-023-00626-7 ↗
5. An overview of microbial indigo-forming enzymes10.1007/s00253-019-10292-5 ↗
6. Paul · 2021
7. Quantification of aniline and N-metahylaniline in indigo10.1038/s41598-021-00634-7 ↗
8. Overview of indigo biosynthesis by flavin-containing monooxygenases: history, induastrialization challenges, and strategies10.1016/j.biotechadv.2024.108374 ↗
9. Auto-inducible synthetic pathway in E. coli enhanced sustainable indigo production from glucose10.1016/j.ymben.2024.07.002 ↗
10. Metabolic engineering of Escherichia coli BL21(DE3) for efficient production of indigo using Methylophaga aminisulfidivorans flavin-containing monooxygenase
11. Research progress, challenges, and perspectives in microbial pigment production for industrial applications - a review
12. Enhancement of indigo production by a metabolically engineered Escherichia coli MG1655 using membrane engineering and two-stage cultivation10.1021/acs.jafc.5c01400 ↗
13. Identification of a novel oxygenase capable of regiospecific hydroxylation of D-limonene into (+)-trans-carveol
14. Cloning and expression in Escherichia coli of the toluene dioxygenase gene from Pseudomonas putida NCIB1176710.1111/j.1574-6968.1989.tb03352.x ↗
15. Enhancing indigo production by over-expression of the styrene monooxygenase in Pseudomonas putida10.1007/s00284-016-1055-3 ↗
16. A combinational optimization method for efficient production of indigo by the recombinant Escherichia coli with expression of monooxygenase and malate dehydrogenase10.3390/foods12030502 ↗
17. Indigoid dyes by group E monooxygenases: mechanism and biocatalysis10.1515/hsz-2019-0109 ↗
18. The extreme structural plasticity in the CYP153 subfamily of P450s directs development of designer hydroxylases10.1021/acs.biochem.8b01052 ↗
19. In vitro characterization of CYP102G4 from Streptomyces cattleya: a self-sufficient P450 naturally producing indigo10.1016/j.bbapap.2017.08.002 ↗
20. Biosynthesis of indigo in Escherichia coli expressing self-sufficient CYP102A from Streptomyces cattleya10.1016/j.dyepig.2017.01.029 ↗
21. Production of indigo through the use of a dualfunction substrate and a bifunctional fusion enzyme
22. Structure-guided engineering of a flavin-containing monooxygenase for the efficient production of indirubin10.1186/s40643-022-00559-7 ↗
23. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients10.2165/11632710-000000000-00000 ↗
24. Plasmid vectors for in vivo selection-free use with the probiotic E. coli Nissle 191710.1021/acssynbio.0c00466 ↗
25. Improved cryptic plasmids in probiotic Escherichia coli Nissle 1917 for antibiotic-free pathway engineering10.1007/s00253-023-12662-6 ↗
26. An Escherichia coli Nissle 1917-based live therapeutics platform with integrated phage resistance and programmable temperature sensitivity
27. Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia10.1038/s41467-024-44776-4 ↗
28. Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism10.1038/s41467-022-31334-z ↗
29. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria10.1038/nbt.4222 ↗
30. Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study10.1038/s42255-021-00430-7 ↗
31. Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial10.1038/s42255-023-00897-6 ↗
32. A novel flavin-containing monooxygenase from Methylophaga sp. strain SK1 and its indigo synthesis in Escherichia coli10.1016/S0006-291X(03)01087-8 ↗
33. Internal dynamics of the tryptophan repressor (TrpR) and two functionally distinct TrpR variants, L75F-TrpR and A77V-TrpR, in their L-Trp bound forms10.1021/bi200389k ↗
34. Multigene editing in the Escherichia coli genome via the CRISPR-Cas9 system10.1128/AEM.04023-14 ↗
35. Improved production of tryptophan in genetically engineered Escherichia coli with TktA and PpsA overexpression
36. Elucidating cysteineassisted synthesis of indirubin by a flavin-containing monooxygenase10.1021/acscatal.9b02613 ↗
37. Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties10.1093/femsle/fnw212 ↗
38. Extending shikimate pathway for the production of muconic acid and its precursor salicylic acid in Escherichia coli10.1016/j.ymben.2014.02.009 ↗
39. Multidimensional engineering of Escherichia coli for efficient synthesis of L-tryptophan10.1016/j.biortech.2023.129475 ↗
40. Metabolic design of a platform Escherichia coli strain producing various chorismate derivatives10.1016/j.ymben.2015.11.007 ↗
41. Central metabolic pathway modification to improve L-tryptophan production in Escherichia coli10.1080/21655979.2019.1592417 ↗
42. YddG from Escherichia coli promotes export of aroamatic amino acids10.1111/j.1574-6968.2007.00894.x ↗
43. Production of indigo by recombinant Escherichia coli with expression of monooxygenase, tryptophanase, and molecular chaperone10.3390/foods11142117 ↗
44. Development of L-tryptophan production strains by defined genetic modification in Escherichia coli10.1007/s10295-011-0978-8 ↗
45. Employing a biochemical protecting group for a sustainable indigo dyeing strategy10.1038/nchembio.2552 ↗
46. Enhanced production of bio-indigo in engineered Escherichia coli, reinforced by cyclopropane-fatty acid-acyl-phospholipid synthase from psychrophilic Pseudomonas sp. B14-610.1016/j.jbiotec.2023.02.008 ↗
47. Indigo and tyrian purple-from ancient natural dyes to modern organic semiconductors10.1002/ijch.201100130 ↗
48. Efficient bioproduction of indigo and indirubin by optimizing a novel terpenoid cyclase XiaI in Escherichia coli10.1021/acsomega.1c02679 ↗
49. Reconstruction of the personal information from human genome reads in gut metagenome sequencing data10.1038/s41564-023-01381-3 ↗
50. Enhancing indican production in Escherichia coli through a multi-faceted experimental strategy